Table 1 Baseline analysis
Characteristics | Experimental group (N = 40) | Control group (N = 18) | Statistics | P |
|---|---|---|---|---|
Age | 54.25 ± 7.48 | 54.17 ± 7.56 | t = 0.04 | 0.969 |
Classification of diseases | – | – | ||
CSEC | 40 (100.00%) | 18 (100.00%) | ||
FIGO staging | χ2 = 5.01 | 0.025 | ||
IIB | 19 (47.50%) | 3 (16.67%) | ||
IIIA+IIIB | 21 (52.50%) | 15 (83.33%) | ||
ECOG score | χ2 = 0.13 | 0.719 | ||
0 | 13 (32.50%) | 5 (27.78%) | ||
1 | 27 (67.50%) | 13 (72.22%) | ||
ANC baseline (×109) | 4.26 ± 1.38 | 4.32 ± 1.74 | t = 0.14 | 0.889 |
Body surface area (m2) | 1.54 ± 0.11 | 1.56 ± 0.17 | t = 0.44 | 0.666 |
Second cycle precursor body surface area (m2) | 1.54 ± 0.11 | 1.56 ± 0.17 | t = 0.44 | 0.666 |